Key Insights

Highlights

Success Rate

87% trial completion (above average)

Published Results

28 trials with published results (16%)

Research Maturity

93 completed trials (54% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

8.1%

14 terminated out of 173 trials

Success Rate

86.9%

+0.3% vs benchmark

Late-Stage Pipeline

23%

39 trials in Phase 3/4

Results Transparency

30%

28 of 93 completed with results

Key Signals

28 with results87% success14 terminated

Data Visualizations

Phase Distribution

122Total
Not Applicable (71)
P 2 (12)
P 3 (19)
P 4 (20)

Trial Status

Completed93
Recruiting22
Unknown22
Terminated14
Active Not Recruiting9
Not Yet Recruiting8

Trial Success Rate

86.9%

Benchmark: 86.6%

Based on 93 completed trials

Clinical Trials (173)

Showing 20 of 20 trials
NCT04738071Active Not Recruiting

International Multicenter Patent foRamen OVale & strokE (IMPROVE) Registry

NCT07271238Not ApplicableRecruiting

Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures

NCT07210151Not ApplicableRecruiting

Anatomical Navigation for Guided Electrophysiology in AFL and AFib

NCT02025465Phase 4Terminated

Randomized Trial Comparing Diltiazem and Metoprolol For Atrial Fibrillation Rate Control

NCT07779746Phase 3Not Yet Recruiting

Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis 2 (SAFE-D2)

NCT04298723Not ApplicableRecruiting

Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.

NCT07501299Recruiting

HeartBeam ECG Registry

NCT05511389Not ApplicableRecruiting

Anteroposterior Versus Anterolateral Electrode Position for Electrical Cardioversion of Atrial Fibrillation

NCT06969378Not ApplicableWithdrawn

Empiric Pulsed Field Pulmonary Vein Isolation During Atrial Tachycardia Ablation in Adults With Congenital Heart Disease

NCT07571447Phase 4Not Yet Recruiting

Cardiologist-Administered Midazolam vs. Anaesthesiologist-Assisted Propofol Sedation For Transoesophageal Echocardiography-Guided Cardioversion of Atrial Fibrillation

NCT05014802Recruiting

Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT07002450Not ApplicableRecruiting

Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)

NCT04267159Not ApplicableRecruiting

Acute Atrial Fibrillation and Flutter Treated Electively

NCT07572279Not Yet Recruiting

Home Monitor for AA Burden Detection IIT in TWN

NCT05416086Not ApplicableTerminated

iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study

NCT05997914Not ApplicableEnrolling By Invitation

Storytelling for Reducing Gap in Anticoagulation Use in African Americans With Atrial Fibrillation

NCT06540352Phase 2Active Not Recruiting

A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form

NCT05635864Completed

Impact of Catheter Ablation on ABC Risk Scores

NCT07447297Not ApplicableRecruiting

Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation

NCT07362134Not ApplicableEnrolling By Invitation

Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter

Scroll to load more

Research Network

Activity Timeline